Total Voting Rights
01 November 2017 15:00 GMT Transparency Directive Voting Rights and Capital The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 31 October 2017 the issued share capital of AstraZeneca PLC with voting rights is 1,265,948,818 ordinary shares of US$0.25. No shares are held in Treasury. Therefore, the total number of voting rights in AstraZeneca PLC is 1,265,948,818. The above figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which